INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 139 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,195,000 | -65.3% | 627,077 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $6,321,000 | +114.3% | 627,077 | +54.0% | 0.00% | +100.0% |
| Q2 2018 | $2,949,000 | -45.7% | 407,297 | -54.7% | 0.00% | -50.0% |
| Q1 2018 | $5,429,000 | -42.7% | 898,911 | -8.8% | 0.00% | -33.3% |
| Q4 2017 | $9,482,000 | +8.3% | 985,712 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,753,000 | -29.8% | 985,712 | 0.0% | 0.00% | -40.0% |
| Q2 2017 | $12,469,000 | +20.4% | 985,712 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $10,360,000 | +204.0% | 985,712 | +166.1% | 0.00% | +300.0% |
| Q4 2016 | $3,408,000 | -3.5% | 370,399 | +18.1% | 0.00% | -50.0% |
| Q3 2016 | $3,533,000 | +3.2% | 313,734 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $3,423,000 | -19.1% | 264,534 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,230,000 | -31.1% | 264,534 | +23.3% | 0.00% | -33.3% |
| Q4 2015 | $6,142,000 | +74.0% | 214,534 | +73.0% | 0.00% | +50.0% |
| Q3 2015 | $3,529,000 | – | 123,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 3,028,354 | $30,526,000 | 0.37% |
| Engineers Gate Manager LP | 96,105 | $969,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,600 | $621,000 | 0.06% |
| GAM Holding AG | 83,940 | $846,000 | 0.03% |
| SHELL ASSET MANAGEMENT CO | 90,282 | $910,000 | 0.02% |
| SFMG, LLC | 11,994 | $107,000 | 0.02% |
| QS Investors, LLC | 159,133 | $1,604,000 | 0.02% |
| Winslow, Evans & Crocker, Inc. | 4,060 | $42,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 285,646 | $2,879,000 | 0.01% |
| PEAK6 Investments LLC | 225,800 | $2,276,000 | 0.01% |